Nova Mentis Life Stock Fundamentals
| HN3Q Stock | EUR 0.02 0.0001 0.57% |
Nova Mentis Life fundamentals help investors to digest information that contributes to Nova Mentis' financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Mentis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Mentis stock.
Nova |
Nova Mentis Life Company Current Valuation Analysis
Nova Mentis' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Nova Mentis Current Valuation | 5.17 M |
Most of Nova Mentis' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Mentis Life is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Nova Mentis Life has a Current Valuation of 5.17 M. This is 99.96% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Germany stocks is 99.97% higher than that of the company.
Nova Mentis Life Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Mentis's current stock value. Our valuation model uses many indicators to compare Nova Mentis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Mentis competition to find correlations between indicators driving Nova Mentis's intrinsic value. More Info.Nova Mentis Life is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Mentis' earnings, one of the primary drivers of an investment's value.Nova Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Mentis' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Mentis could also be used in its relative valuation, which is a method of valuing Nova Mentis by comparing valuation metrics of similar companies.Nova Mentis is currently under evaluation in current valuation category among its peers.
Nova Fundamentals
| Return On Equity | -0.89 | |||
| Return On Asset | -0.52 | |||
| Current Valuation | 5.17 M | |||
| Shares Outstanding | 143.47 M | |||
| Shares Owned By Insiders | 11.73 % | |||
| Shares Owned By Institutions | 0.01 % | |||
| Price To Book | 4.41 X | |||
| Price To Sales | 4,602 X | |||
| Gross Profit | (5.44 K) | |||
| EBITDA | (2.93 M) | |||
| Net Income | (2.68 M) | |||
| Cash And Equivalents | 1.51 M | |||
| Cash Per Share | 0.01 X | |||
| Current Ratio | 9.07 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.95 M) | |||
| Earnings Per Share | (0.01) X | |||
| Beta | 0.86 | |||
| Market Capitalization | 4.65 M | |||
| Total Asset | 881.16 K | |||
| Z Score | -9.9 | |||
| Net Asset | 881.16 K |
About Nova Mentis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Mentis Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Mentis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Mentis Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Nova Mentis Life Science Corp., through its subsidiaries, engages in the research and development of medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. NOVA MENTIS is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova Stock
Nova Mentis financial ratios help investors to determine whether Nova Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.